Predictors of Pathological Progression among Men with Localized Prostate Cancer Undergoing Active Surveillance: a Sub-Analysis of the REDEEM Study
Authors:
- 1 December 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 190 (6) , 2039-2046
Abstract
Purpose: We identify risk factors for pathological progression among men on active surveillance in the REDEEM (REduction by Dutasteride of clinical progression Events in Expectant Management trial)...Keywords
Funding Information
- GlaxoSmithKline
This publication has 22 references indexed in Scilit:
- The Relationship Between Prostate Specific Antigen Change and Biopsy Progression in Patients on Active Surveillance for Prostate CancerJournal of Urology, 2011
- Risk Stratification and Validation of Prostate Specific Antigen Density as Independent Predictor of Progression in Men With Low Risk Prostate Cancer During Active SurveillanceJournal of Urology, 2011
- Quality-of-Life Impact of Primary Treatments for Localized Prostate Cancer in Patients Without Hormonal TreatmentJournal of Clinical Oncology, 2010
- Outcomes in Localized Prostate Cancer: National Prostate Cancer Register of Sweden Follow-up StudyJNCI: Journal of the National Cancer Institute, 2010
- Risk Stratification of Men Choosing Surveillance for Low Risk Prostate CancerJournal of Urology, 2010
- Clinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort With Localized Prostate CancerJournal of Clinical Oncology, 2010
- Quality of Life and Satisfaction with Outcome among Prostate-Cancer SurvivorsNew England Journal of Medicine, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Predictors of Histological Disease Progression in Untreated, Localized Prostate CancerJournal of Urology, 2007
- Delayed Versus Immediate Surgical Intervention and Prostate Cancer OutcomeJNCI: Journal of the National Cancer Institute, 2006